Compare Vanguard Emerging Markets Stock Index Fund ETF (VWO) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vanguard Emerging Markets Stock Index Fund ETF vs State Street SPDR S&P Biotech ETF — how do they compare? Vanguard Emerging Markets Stock Index Fund ETF trades at $58.85, while State Street SPDR S&P Biotech ETF trades at $154.5. Which is the better fit depends on your goals.
| VWO | XBI | |
|---|---|---|
52-Week High | $61.24 | $164.28 |
52-Week Low | $49.54 | $85.16 |
Sector | — | Broad Market / Factor |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Vanguard Emerging Markets Stock Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the FTSE Emerging Markets All Cap China A Inclusion Index. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the index in terms of key characteristics.
Read more on VWO →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
